“…It follows an autosomal recessive inheritance pattern and is clinically marked by leukocytoclastic vasculitis, thrombocytopenia, immune defects, eczema, otitis media, and bloody eosinophilic colitis. ARPC1B deficiency in T cells impairs immune synapse formation and the targeted release of lytic granules, ARP2/3-dependent processes, which helps to explain the reported immune defects ( 3 , 4 ). Similar to WAS, ARPC1B-deficient patients also have increases in circulating CD19 + cells, soluble IgE, sIgA, and autoantibodies, which is suggestive of an intrinsic, autoactivated B cell compartment ( 1 , 5 , 6 ).…”